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/ajh/article-abstract/20/7/728/1239Background: The effect of dietary pomace olive oil,
which has the same concentration of oleic acid but a
higher proportion of oleanolic acid (OA) than olive oil,
was examined on animal models of hypertension for the
first time.
Methods: During 12 weeks, Wistar Kyoto (WKY) and
spontaneously hypertensive rats (SHR) were fed with ei-
ther a control 2% corn oil diet (BD), or high-fat diets
containing 15% of refined olive oil (OL), pomace olive oil
(POM), or pomace olive oil supplemented in OA (up to
800 ppm) (POMO). Then, vascular reactivity and endo-
thelial nitric oxide (NO) synthase (eNOS) expression were
studied in aortic rings. Plasma nitrite  nitrate levels were
also determined.
Results: Diets had no effects on blood pressure (BP). In
contrast to the BD and OL dietary groups, POM intake
improved relaxation evoked by acetylcholine in SHR
aorta. The POMO intake increased vasodilatation to ace-
tylcholine and attenuated phenylephrine-induced contrac-
tions in both strains of rats associated with a major NO
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doi:10.1016/j.amjhyper.2007.01.012participation revealed by inhibition of NOS. The enhanced
relaxation shown in POM and POMO SHR aorta was
attributed to an increased eNOS protein expression.
Plasma nitrite levels were also increased in these groups.
Although olive and pomace oils used in diets contained
similar fatty acid composition, beneficial effects on endo-
thelial function were absent in the OL group. Therefore,
these effects must be associated with some minor compo-
nents from pomace olive oil such as OA.
Conclusions: Chronic intake of diets rich in pomace
olive oil improves endothelial dysfunction in SHR aorta
by mechanisms associated with enhanced eNOS expres-
sion. Important evidence is provided regarding the effects
of pomace olive oil and OA on endothelial function in hy-
pertensive animals. Am J Hypertens 2007;20:728–734
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ay 2020M ajor cardiovascular risk factors such as hyper-tension and diabetes have been found to occurwith endothelial dysfunction. In these circum-
stances, there is an imbalance in the production of relaxing
and contracting substances from the endothelium and
thus endothelium-dependent vasodilatation is impaired, as
manifested in the aorta of hypertensive rats.1 Epidemio-
logic studies focused on dietary patterns from Mediterra-
nean countries have demonstrated that olive oil intake
decreases the incidence of cardiovascular disease.2–4 The
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ay 2020Pomace or orujo olive oil, as it is called in Spain, is
obtained from the residue that remains after virgin olive
oil mechanical extraction. As a consequence of the chem-
ical processes needed to obtain both refined olive and
pomace olive oils, the hydrosoluble fraction, including
phenolic compounds, is lost. In spite of the lack of poly-
phenols, pomace olive oil contains higher concentrations
of triterpenoids than olive oil.13 Oleanolic acid (OA), one
of the main triterpenoids in pomace olive oil, has been
associated with a wide range of biological activities (for
review, see Herrera et al14). Recent research has demon-
strated that chronic administration of OA prevents hyper-
tension in salt-sensitive rats.15 Furthermore, OA is able to
induce in vitro endothelium- and nitric oxide (NO)–de-
pendent vasorelaxation of the aorta from normotensive10
and hypertensive rats.11 In addition, it has been reported
that chronic ingestion of pomace olive oil with a high
proportion of OA attenuates lipid peroxidation in rat liver
microsomes.16 Nevertheless, the effects of pomace olive
oil intake on endothelial dysfunction due to hypertension
have not been analyzed. Therefore, the purpose of this
study was to evaluate the preventive effects of long-term
intake of pomace olive oil in the development of hyper-
tension and endothelial dysfunction in spontaneously hy-
pertensive rats (SHR) in comparison with its normotensive
control, Wistar Kyoto (WKY) rats. In addition, we exam-
ined the effects of OA supplementation to pomace olive oil
in the parameters evaluated. Finally, we tried to identify
the role of NO and endothelial NO synthase (eNOS)
expression levels in the protection against endothelial dys-
function after a diet enriched with pomace olive oil with or
without additional OA. The involvement of prostanoids
derived from the endothelium was also evaluated.
Methods
Animals and Diet Preparation
All experiments were approved by the Institutional Com-
mittee on Investigation in Animals (University of Seville,
Seville, Spain). Three-week-old male WKY and SHR
(Charles River, Barcelona, Spain) were housed at constant
temperature (24°  2°C) and a 12-h light–dark cycle.
During 12 weeks, animals were fed either a control low-fat
diet (basal diet, BD) containing 2% (w/w) corn oil, or
high-fat diets containing 15% (w/w) refined olive oil,
pomace olive oil (POM), and pomace olive oil supple-
mented with OA up to 800 ppm (POMO). The original
POM contains 200 ppm of OA. Food components were
purchased from Musal & Chemical (Granada, Spain) and
ICN Nutritional Biochemicals (Cleveland, OH). Olive and
pomace oils were provided from Oleotejar (Cordoba,
Spain) and corn oil from Koipe (Jaen, Spain). Oleanolic
acid was obtained from olive leaves17 and diets were
prepared as described.18 The fatty (Table 1) and nonfatty
acid composition of the oils was analyzed by gas chroma-
tography in Oleotejar. Food intake, corporal weight, heart
rate, and systolic blood pressure (BP) of the animals weredetermined every week. The latter measurements were
performed in conscious rats by tail–cuff plethysmography
(Niprem 645; Cibertec, Spain). At the end of this period,
animals were anesthetized with pentobarbitone (60 mg/kg)
and blood was collected by intracardiac puncture.
Arterial Preparation and
Vascular Reactivity Studies
Aortic segments were mounted as described.10 The pres-
ence of functional endothelium was determined by the
ability of 1 mol/L acetylcholine (ACh) to induce relax-
ation of vessels precontracted with 1 mol/L phenyleph-
rine (Phe). In some arteries, endothelium was removed by
gently rubbing the inner surface.
The first series of experiments included the responses
evoked by cumulative addition of Phe (1 nmol/L to 100
mol/L) for aortic rings with or without endothelium and
expressed as the percentage of 80 mmol/L KCl-induced
contraction. In the second series of experiments, endothe-
lial function was evaluated by adding cumulative concen-
trations of ACh (1 nmol/L to 10 mol/L) to arteries
precontracted with Phe (0.3 and 1 mol/L for WKY and
SHR, respectively). To evaluate the involvement of NO,
curves were performed in the presence of the NO synthase
inhibitor N-nitro-L-arginine (L-NAME 300 mol/L). The
ACh-evoked relaxation was also tested in the presence of
indomethacin (10 mol/L) to evaluate the implication of
prostanoids derived from cyclooxygenase (COX).
eNOS Detection by Western Blotting
Aortic rings were homogenized in lysis buffer and 30 g
of protein were loaded into 7% sodium dodecyl sulfate
(SDS)–polyacrylamide gel to separate eNOS.19 Immuno-
blotting was achieved using a specific monoclonal mouse
anti-eNOS (1:2500; BD Transduction Laboratories, San
Diego, CA) and then with the secondary peroxidase-con-
jugated antibody (1:5000; Sigma Chemical Co., St. Louis,









Myristic (14:0) 0.01 0.02 0.02
Palmitic (16:0) 10.36 10.98 10.29
Palmitoleic (16:1,
n-7) 0.12 0.82 0.76
Stearic (18:0) 2.36 3.53 2.95
Oleic (18:1, n-9) 33.05 77.80 74.27
Linoleic (18:2, n-6) 50.89 4.52 8.07
-Linolenic (18:3,
n-3) 0.71 0.62 0.70
Arachidic (20:0) n.d. 0.42 0.45
n.d.  not detected.
* Corn oil included in a 2% basal diet (BD); † Olive oil (OL diet)
and pomace olive oil (POM and POMO diets) are both refined oils.MO). The blots were detected by chemiluminiscence
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ay 2020(Pierce Chemical Company, Rockford, IL) and evaluated
by densitometry. The sample loading was verified by staining
membranes with Ponceau red and by immunostaining with
monoclonal mouse anti--actin (1:5000; Sigma).
Plasma Nitrite Determination
Plasma samples were incubated with nitrate reductase to
reduce nitrates to nitrites and final concentration (NOx)
was determined by adding Griess reagent to the sample
and measuring the absorbance at 540 nm.20 The NOx
concentrations were expressed as mol/L and calculated
using a standard curve of nitrite.
Calculations and Statistical Evaluation
Relaxations were expressed as a percentage from the ini-
tial contraction level and as mean  SEM for n experi-
ments. The maximum contraction (Emax values) and the
concentration of the agonist producing 50% of maximum
vasoconstrictor response expressed as negative log molar
(pD2  logEC50) were calculated by nonlinear regres-
sion analysis of each individual concentration–response
curve using GraphPad Prism Software 3.0 (San Diego,
CA). Data were analyzed using one-way analysis of vari-
ance (ANOVA) followed by Fisher’s multiple comparison
test. Differences were considered significant when P  .05.
Results
Hemodynamic Parameters
At the end of the administration period body weight and
food intake were not substantially different in WKY or
SHR (Table 2). Systolic BP increased in SHR compared
with WKY after 12 weeks of treatment (Table 2). Neither
BD nor high-oil diets were able to attenuate the systolic
BP increase in SHR groups (Table 2). Likewise, heart rate
was not different among groups during treatment (data not
shown).
Table 2. Body weight, food intake, and systolic
(4-week-old) and after 12 weeks of dietary administ
Body weight (g) Food
Before After Befor
WKY
BD 64.5  1.0 337.0  3.1*** 15.0 
OL 56.5  2.2 336.7  8.1*** 15.5 
POM 65.6  3.1 357.0  8.9*** 16.0 
POMO 65.0  3.2 348.7  16.9*** 16.2 
SHR
BD 64.0  3.7 328.6  6.7*** 16.0 
OL 63.2  2.6 318.0  7.5*** 15.0 
POM 58.4  2.1 320.3  8.5*** 14.8 
POMO 58.0  2.5 317.0  5.1*** 15.0 
BD  basal diet, rich in corn oil; OL  olive oil; POM  pomace oliv
Data represented are mean  SEM.
** P  .001 v values before treatment from the same dietary group;Contractile Response to Phenylephrine
Phenylephrine-induced contractions were notably attenu-
ated in SHR intact aortic segments in comparison with
those exhibited in WKY groups (Table 3). Feeding nor-
motensive WKY with POMO diet significantly reduced
contractile responses evoked by Phe in aortic rings with
endothelium compared with the BD group (P  .01; Table
3). On the contrary, POM intake increased Phe-induced
contractions in WKY aortas (P  .05; Table 3). Removal
of endothelium augmented Emax to Phe in all WKY
groups, whereas incubation with L-NAME only enhanced
Emax values in olive oil– and POMO-fed WKY (Table 3).
Although either incubation with L-NAME or endothelium
removal increased the effect of Phe on POMO-treated
WKY, the contraction to Phe was still attenuated com-
pared with the other groups (P  .05; Table 3). With
regard to SHR, the POMO diet intake also attenuated
concentration–response curves to Phe in intact aortic rings
in comparison with the BD hypertensive dietary group
(P  .05; Table 3). Either endothelial removal or NOS
inhibition increased maximal contractile response to Phe
in all SHR groups compared with intact aortic rings (Table
3). Altogether, these results indicate that POMO intake
involves endothelium-dependent mechanisms to decrease
Phe-evoked contractions in SHR aortic rings.
Endothelium-Dependent Relaxation
The Ach-induced relaxation in aortic rings with endothe-
lium precontracted with Phe (Fig. 1). Aortas taken from
both WKY and SHR fed the POMO diet showed an
increased relaxation to ACh compared with those from the
strain-matched BD group (P  .05; Fig. 1). Likewise,
ACh-evoked relaxation was enhanced in aortas taken from
POM-treated SHR (P  .05; Fig. 1b). In aortas from WKY
rats, the relaxant response to ACh was abolished in the
presence of the NOS inhibitor L-NAME (P  .001; Fig. 2),
thus indicating NO involvement in the relaxant response to
d pressure (SBP) from WKY and SHR rats before
n (16-week-old)
ake (g/day) SBP (mm Hg)
After Before After
22.1  1.0*** 148.1  4.6 164.4  3.6††
21.0  1.5*** 141.4  5.8 162.4  3.3†††
21.6  1.3*** 137.4  3.9 153.8  2.9†††
23.5  1.9*** 140.5  1.6 149.9  0.7†††
25.0  0.5*** 136.7  5.0† 194.9  8.9***
26.0  0.4*** 125.0  4.5† 207.5  4.5***
23.2  1.1*** 124.3  5.6† 191.9  7.1***
22.8  0.4** 131.3  8.4† 193.5  6.9***












e oil;*** P  .001; †† P  .01; ††† P  .001 v diet-matched SHR.
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with indomethacin. These conditions did not modify en-
dothelial function in normotensive aortas from both BD
and olive oil groups (Fig. 2a,b). Interestingly, COX inhi-
bition enhanced vasorelaxation to ACh in POM- and
POMO-treated WKY (P  .05; Fig. 2c,d). Finally, com-
bination of L-NAME plus indomethacin did not elicit addi-
tional inhibition than incubation with only L-NAME (Fig. 2).
In aortas from all groups of SHR, the ACh-evoked
relaxation was not completely abolished by L-NAME,
suggesting the possible involvement of an NO-indepen-
dent mechanism (Fig. 3). Because the combination of
indomethacin and L-NAME completely blocked the relax-
ation, this points to the participation of prostanoids on the
relaxant effect promoted by ACh (Fig. 3). In addition, in
rings from BD SHR, the presence of indomethacin im-
proved the relaxant response to the muscarinic agonist,
revealing the involvement of COX-derived constrictor prod-
Table 3. Emax and pD2 values in response to ph
mol/L) in isolated rat aortic rings with (E) or wi
synthase inhibitor N-nitro-L-arginine (L-NAME) with
Emax (% maximal contraction
E L-NAME
WKY
BD 124.8  9.8 149.1  12.9 192.6 
OL 124.6  9.0 165.1  16.3# 168.3 
POM 153.8  8.6* 168.4  10.2 187.0 
POMO 79.6  4.6** 119.3  2.7*# 151.0 
SHR
BD 98.0  4.0† 120.9  6.0†# 160.6 
OL 97.1  9.8† 118.9  6.4††# 142.7 
POM 100.1  7.3†† 122.7  7.9††# 150.3 
POMO 70.4  2.6* 106.8  6.8### 138.7 
Abbreviations as in Table 2.
Data represented are mean  SEM.
* P  .05; ** P  .01 v strain-matched BD; † P  .05; †† P  .0
and group-matched E.
FIG. 1. Relaxation induced by acetylcholine (ACh, 1 nmol/L to 10
mol/L) of intact aortic rings from either Wistar Kyoto (WKY) rats
(A) or spontaneously hypertensive rats (SHR) (B) fed with 2% corn
oil diet (BD) (’, low-fat, basal diet), 15% of refined olive oil (OL)
(), pomace olive oil (POM) (Œ), or pomace olive oil supplemented
in OA (POMO) (●) for 12 weeks. Values are mean  SEM, n  5 to 6
rats. Statistical analysis of concentration–response curves. *P  .05
v BD group.ucts (P  .05; Fig. 3a). In contrast, indomethacin failed to
enhance ACh-induced relaxation in SHR aorta from POM
and POMO groups compared with the BD group (Fig. 3).
This suggests that the POM and POMO diets may have
inhibitory effects on contractile prostanoids.
eNOS Expression and NOx Levels
Compared with WKY, BD- and olive oil–treated SHR
exhibited a significant reduction of aortic eNOS protein
lephrine cumulative contractions (1 nmol/L to 100




.4# 7.56  0.21 7.19  1.34 7.58  0.59
.7# 7.73  0.53 7.58  0.47 8.22  0.10
.8# 7.72  0.56 7.41  0.97 7.81  0.72
8*# 7.74  0.25* 7.51  0.54* 8.11  0.07
.2## 6.95  3.93 7.22  2.24 7.67  0.34
0## 7.00  3.13 7.55  0.20 7.63  1.05
9## 7.12  1.54 7.04  2.55 7.71  0.30
1## 7.16  0.70 7.20  1.09 7.78  0.19*
iet-matched WKY; # P  .05; ## P  .01; ### P  .001 v strain-
FIG. 2. Relaxation of intact aortic rings induced by ACh (1 nmol/L to
10 mol/L) in WKY rats fed with either BD (low-fat, basal diet; (A),
OL (B), POM (C), or POMO (D) for 12 weeks. Concentration–re-
sponse curves were obtained in the absence (Œ, taken as control) or
presence of N-nitro-L-arginine (L-NAME) (●) (300 mol/L), indo-













1 v dare mean  SEM, n  5 to 6 rats. Statistical analysis of concentra-
tion–response curves. *P  .05; ***P  .001 v control.
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in aortas from POM and POMO-treated SHR was signif-
icantly enhanced compared with those from BD and olive
oil and reached values that were similar to those from
WKY rats (Fig. 4).
As shown in Table 4, there was no difference among
plasma NOx levels in BD-fed WKY and SHR. Feeding
FIG. 3. Relaxation of intact aortic rings induced by ACh (1 nmol/L to
10 mol/L) in SHR fed with either BD (low-fat, basal diet; (A), OL
(B), POM (C), or POMO (D) for 12 weeks. Curves were obtained in
the absence (Œ, taken as control) or presence of L-NAME (●) (300
mol/L), indomethacin (□) (INDO; 10 mol/L), or INDO plus L-
NAME (). Values are mean  SEM, n  5 to 6 rats. Statistical
analysis of concentration–response curves. *P  .05; ***P  .001 v
control; †P  .05; †††P  .001 v INDO  L-NAME.
FIG. 4. (A) Representative blots of eNOS in aorta homogenates
from WKY and SHR fed with BD (low-fat, basal diet), OL, POM, or
POMO for 12 weeks. a-actin  --actin; eNOS  endothelial nitric
oxide synthase. (B) Bands showing optic densitometry of n  4
blots. *P  .05 v strain-matched BD; †P  .05; ††P  .01 v dietary
group-matched WKY.either WKY or SHR with POMO significantly enhanced
plasma NOx levels (48.4% and 65.1%, respectively) com-
pared with the BD group. In contrast, POM intake only
enhanced NOx in SHR but not in WKY (43.3% and
17.7%, respectively, versus the BD group).
Discussion
The purpose of this study was to evaluate the effects of
pomace olive oil intake on endothelial dysfunction asso-
ciated with hypertension as well as to determine the influ-
ence of higher concentrations of OA on the effects of diets
enriched with pomace olive oil. The main result from the
present study shows that dietary administration of pomace
olive oil enhances endothelium-dependent relaxation to
ACh in isolated aorta from SHR and the mechanism
primarily involves NO by increasing eNOS protein ex-
pression. Oleanolic acid seems to contribute to these ben-
eficial effects.
Cumulative evidence suggests that monounsaturated
fatty acids may be the key component in the healthy
properties elicited by olive oil intake in endothelial func-
tion and vascular inflammatory markers.5,21 Nevertheless,
controversies have been reported regarding the beneficial
effects of oleic acid in terms of cardiovascular events such
as hypertension.22,23 A wide range of the cardioprotective
effects of virgin olive oil consumption has also been at-
tributed to its high concentration in biologically active
polyphenols.24 However, in our study we used refined
olive oils, instead of virgin olive oil, which are lacking in
polyphenols (water-soluble fraction) after the refining pro-
cesses. Both refined olive oil and pomace olive oil pre-
sented similar oleic acid proportions but different
concentrations in other minor components.
In the present study, hypertensive rats fed pomace olive
oil–enriched diets (POM or POMO), but not olive oil–fed
animals, showed increased endothelium-dependent ACh
relaxations. This finding highlights the fact that other
components, different from oleic acid such as minor con-
stituents included in the unsaponifiable fraction of the oils,
might be responsible for the long-term response of pomace
Table 4. Plasma NOx (nitrites  nitrates) from




BD 4.4  0.3 4.7  0.3
OL 4.5  0.2 5.8  0.6*
POM 5.2  0.02 6.8  0.9*†
POMO 7.3  0.9† 7.1  0.3†
Abbreviations as in Table 2.
Data represented are mean  SEM.
* P  .05 v diet-matched WKY; † P  .05 v strain-matched BD.olive oil intake on endothelium. Triterpenoids, such as
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research group has recently demonstrated a novel in vitro
vasodilator effect of OA in aortas from hypertensive rats.11
In our investigation we have used SHR, which have
been characterized by endothelial dysfunction,1 with an
important impairment of NO availability. In addition, a
structural feature of this hypertensive rat model is an
increased arterial stiffness that reduces contractility in
vitro, possibly due to vessel rigidity in vivo,25 as con-
firmed in our results. In the present study, we have found
that chronic supplementation of pomace olive oil with OA
(POMO) improves endothelial function, not only in aorta
from SHR, but also in that from WKY. In addition, aortas
from SHR fed with POMO, but not with POM, showed a
decreased concentration–response to Phe compared with
the BD diet, supporting the hypothesis that OA could be
responsible, at least partly, for these effects.
Because BP was not modified by any of the diets
assayed, we cannot explain the endothelial function im-
provement associated with POM and OA in diet by a
secondary event to antihypertensive effect but by their
protective action in the vascular endothelium. In contrast
to these results, chronic administration of OA prevented
hypertension in another rat model of this disease.15 How-
ever, this antihypertensive effect has been shown with
higher dose of OA (60 mg/kg) and after intraperitoneal
administration.15 In comparison, in our study OA was
administered as part of the diet and consequently by oral
intake and at a lower dose. Therefore, differences in ex-
perimental design such as administration routes and mea-
surements of BP could explain the results. We hypothesize
that the intake of a diet enriched in POM could protect
vascular walls and, consequently, promoting target organs
protection independent of BP, which is one of the most
important objectives in hypertensive patients. Neverthe-
less, this therapeutic effect requires further studies.
Regarding the role played by NO in endothelial dys-
function associated with hypertension, it is known that a
decreased NO bioavailability as a consequence of an in-
creased superoxide production is a relevant event contrib-
uting to the endothelial disturbances in SHR.1,26 In
addition, eNOS expression and activity has been reported
to change in hypertensive rats depending on the age and
the tissue studied.27 According to a previous report,28 at
the age of 16 weeks we have found lower eNOS protein
expression levels on aortas from BD SHR when compared
with diet-matched WKY rats. In the present investigation,
exposure of aortic rings to L-NAME revealed higher par-
ticipation of NO in Ach relaxation of SHR fed with either
POM or POMO compared with endothelium curves in the
absence of any inhibitor. In contrast, SHR-BD exhibited
lower NO involvement compared with L-NAME versus
control Ach curves. Furthermore, Phe-induced responsive-
ness of intact aortas from WKY and SHR fed with POMO
was attenuated; this effect was reverted by L-NAME,
suggesting partial NO involvement. Accordingly, an in-
creased NO bioavailability in these dietary groups wasconfirmed by an enhanced plasma concentration of NO
end products (NOx). In addition, we found that either the
POM or the POMO diet restored eNOS expression in SHR
toward values found in WKY. Many hypotheses can ex-
plain these results, such as prevention of eNOS degrada-
tion, increase of eNOS transcription, or even an increase
of mRNA stability by posttranscriptional mechanisms.
Nevertheless, further experiments should be carried out to
identify the mechanisms underlying the higher eNOS pro-
tein levels. In spite of the increased NO participation in
endothelium-dependent relaxation observed in arteries
from POMO WKY, eNOS expression remains unaltered,
suggesting that other mechanisms, such as an increased
eNOS activity or a reduction of reactive oxygen species,
could be involved in this event. It is important to take into
account that, to our knowledge, there are not many studies
in the literature regarding the regulation of eNOS expres-
sion due to dietary modifications in genetic hypertensive
rats. Our investigation provides a novel and relevant up-
regulation of eNOS in SHR aortic homogenates by long-
term intake of POM. This fact may be considered as a
reasonable and realistic strategy for the prevention or
therapy of cardiovascular diseases including hypertension.
In addition to the decreased NO availability, factors
derived from COX play a crucial role in the endothelial
dysfunction associated with hypertension.29 In the present
investigation, the enhancement of the ACh-induced relax-
ation in the presence of the COX inhibitor observed in BD
SHR, confirmed the participation of contractile products
from this metabolic pathway. On the contrary, high fat
intake was able to prevent the implication of contracting
COX products in endothelium-dependent relaxation. In
addition to contractile prostanoids, the COX pathway gen-
erates vasodilator products such as PGI2. According to
previous reports, which showed an increased release of
PGI2 in SHR,
29 our results in the presence of L-NAME
revealed the involvement of a relaxant factor different
from NO that was inhibited by indomethacin, thus indi-
cating that maybe it is COX derived. The participation of
this relaxant COX product, which was masked by NO in
basal conditions, remained unaltered in all SHR groups.
Contribution of this prostanoid may explain the fact that in
POM and POMO SHR, with higher NO availability, a
residual relaxation to ACh was found after L-NAME in-
cubation.
Conversely, normotensive rats fed with POM or POMO
showed an increase in the resulting COX-derived contract-
ing component. These findings agree with previous re-
ports, where differences in fatty acid composition of
dietary oils play an important role in modulating eico-
sanoids production and lipoprotein peroxidation.30 We
could hypothesize that the presence of monounsaturated
fatty acid such as oleic acid could be responsible for
contracting prostanoids in SHR fed with high- or low- fat
diets, whereas minor constituents such as triterpenoids
could contribute to the increased implication of COX
products in conductance arteries in WKY rats receiving a
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ay 2020POM-enriched diet. Nevertheless, further studies are re-
quired to better characterize the role of endothelial COX
products in rats after diet administration with either POM
or POMO.
In conclusion, the main finding of this study shows that
oral intake of a diet enriched in pomace olive oil, rich in
minor constituents such as OA, increased endothelial NO-
mediated relaxation of aortic rings through an enhanced
eNOS expression in SHR. This is the first report on the
cardiovascular properties of pomace olive oil intake and it
contributes to the pharmacologic relevance of OA supple-
mentation. The fact that OA improved endothelial function
of hypertensive rats without altering BP suggests the po-
tential use of OA as an adjuvant to hypertension therapy.
Finally, the information provided in this study is of im-
portance for the traditional use of pomace olive oil by the
Spanish population and thus for the Mediterranean diet.
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